Bristol-Myers Finds a $74 Billion Biotech Bargain
Bristol-Myers Squibb Co. brand medication sits on a pharmacy shelf in Provo, Utah, U.S. (Photographer: George Frey/Bloomberg)

Bristol-Myers Finds a $74 Billion Biotech Bargain

Bookmark
(Bloomberg Opinion) -- During the past 16 months, Celgene Inc. has gone from biotech darling to pariah after a series of research fumbles. On Thursday, Bristol-Myers Squibb Co. — which has had its ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.